ÂÜÀòÂÒÂ×

Brian Schmidt is a Senior Director at AbbVie, leading Drug Substance Development in Biologics CMC Development since 2022. Previously, they held roles as Associate Director in Analytical Development at Facet Biotech and Abbott, and Senior Scientist at PDL BioPharma, contributing significantly to the development of biologics such as monoclonal antibodies and antibody drug conjugates. Brian earned a Ph.D. in Chemistry from the University of California, Davis, following a B.S. in Chemistry from George Fox University. Their extensive experience in analytical and bio-process development has positioned them as an influential leader in the pharmaceutical industry.